Back to Journals » OncoTargets and Therapy » Volume 13
Original Research
MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,904 | Dovepress* | 4,517+ | 756 | 5,273 | |
PubMed Central* | 387 | 101 | 488 | ||
Totals | 4,904 | 857 | 5,761 | ||
*Since 17 August 2020 |
View citations on PubMed Central and Google Scholar